Doctor Vaughan's COVID-19 Updates
By Mark Vaughan
Dr. Vaughan is the Medical Director of the Auburn Medical Group. He also serves on the Board of Directors for Sutter Independent Physicians. Learn about the Auburn Medical Group at auburnmedicalgroup.com.
Other podcasts : vaughanmd.com
Doctor Vaughan's COVID-19 UpdatesJun 22, 2020
Pan Coronavirus Vaccine
The decision was made this week to create a pan coronavirus vaccine which would greatly decrease the need for vaccine boosters.
4th Shot for Over 50
Who Gets a 4th Shot?
Free Home COVID Tests
We are rapidly approaching the peak of Omicron and the resolution of the pandemic. Welcome to the endemic.
Omicron is Here
Omicron is Here
Is Omicron Good?
Boosters for All Adults
Everyone over age 18 is now eligible for a booster 6 months after receiving their second mRNA vaccine dose.
Pfizer Vs. Moderna
Pfizer Now for Kids
Cerebral Venous Sinus Thrombosis with Johnson & Johnson Vaccine
The Johnson and Johnson COVID vaccine has an association with a blood clot in the veins around the brain. It is rare, and it is 30 times more rare in the group most likely to experience it than severe effects of COVID 19 if they don't get the vaccine. This is not a problem with the mRNA vaccines by Pfizer and Moderna.
Can't Vaccinate Children Yet
Approval of the Pfizer vaccine in children, age 5 - 11, is likely to occur after going through review at the FDA, the ACIP, and then the CDC. Send in a voice message to tell me what you think of the video format.
Final Booster Recommendations
ACIP Vaccine Booster Recommendation
We Have Same-Day PCR Testing
Is J&J Actually a Two Shot Vaccine?
The FDA VRBPAC recommends a booster for Johnson & Johnson vaccines for everyone who received the first dose. This will be considered by the FDA.
Third Moderna Shot Recommended
The FDA’s VRBPAC has recommended certain individuals to receive a third dose if the Moderna COVID vaccine.
Placer County COVID Numbers Update
National Guard Called to Four California Hospitals
A Second Johnson & Johnson Dose
Over the Peak
Pfizer Booster Update
Pfizer Booster Approved
The FDA approved administration of a booster to certain groups for the Pfizer Covid vaccine. It is an emergency use authorization for individuals 65 years old and older, people at risk occupationally or due to institutionalization and people with certain high risk conditions. It is given at least 6 months after completing the initial two-shot series.
FDA VRBPAC Third Shot Clarification
The FDA Vaccines and Related Biologic Products Advisory Committee voted against recommending a third dose to individual 16 years of age to 64 years of age. They did approve a recommendation for giving a third shot to individuals 65 years of age and older. This has not been approved by the FDA yet. It is likely they will approve it shortly.
No Boosters for Now
Miscarriages and COVID Vaccines
LA Summer COVID Vaccine Study
What will Booster Shots Be?
Who Exactly Counts as Immunosuppressed?
The CDC has clarified who is considered immunocompromised enough to receive the third dose of mRNA vaccines.
The ACIP of the CDC and the FDA have agreed on appending the Emergency Use Authorization for the mRNA vaccines in individuals who are moderately to severely immunocompromised to receive a third dose booster. This includes people who have:
Been receiving active cancer treatment for tumors or cancers of the blood
Received an organ transplant and are taking medicine to suppress the immune system
Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response